• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

靶向整合含有新霉素抗性基因的转染和感染腺相关病毒载体。

Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene.

作者信息

Shelling A N, Smith M G

机构信息

Biochemistry Department, University of Otago, Dunedin, New Zealand.

出版信息

Gene Ther. 1994 May;1(3):165-9.

PMID:7584077
Abstract

Human adeno-associated virus (AAV) integrates specifically into a site (AAVS1) on chromosome 19q13.3-qter. We report that both transfected and infected AAV-vectors will target a foreign gene preferentially to AAVS1. Of 11 infected cell lines studied, nine (82%) showed integration of the neomycin resistance marker into AAVS1, which confirms the findings of previous investigations. We also show site-specific integration (nine out of 12 cell lines, 75%) following transfection of an AAV vector containing the neomycin gene. The ability of transfected AAV sequences to preferentially target and express selectable genes at a known site in the human genome extends the potential use of AAV as a vector in gene therapy.

摘要

人类腺相关病毒(AAV)特异性整合到19号染色体q13.3 - qter区域的一个位点(AAVS1)。我们报告,无论是转染的还是感染的AAV载体都会优先将外源基因靶向AAVS1。在所研究的11个感染细胞系中,9个(82%)显示新霉素抗性标记整合到AAVS1中,这证实了先前研究的结果。我们还展示了转染含有新霉素基因的AAV载体后出现的位点特异性整合(12个细胞系中的9个,75%)。转染的AAV序列优先靶向人类基因组中一个已知位点并表达可选择基因的能力扩展了AAV作为基因治疗载体的潜在用途。

相似文献

1
Targeted integration of transfected and infected adeno-associated virus vectors containing the neomycin resistance gene.靶向整合含有新霉素抗性基因的转染和感染腺相关病毒载体。
Gene Ther. 1994 May;1(3):165-9.
2
Chromosomal latency and expression at map unit 96 of a wild-type plus adeno-associated virus (AAV)/Neo vector and identification of p81, a new AAV transcriptional promoter.野生型腺相关病毒(AAV)/Neo载体在96图距单位处的染色体潜伏与表达以及新型AAV转录启动子p81的鉴定。
J Hum Virol. 1999 Nov-Dec;2(6):359-68.
3
Site-specific integration of adeno-associated virus-based plasmid vectors in lipofected HeLa cells.基于腺相关病毒的质粒载体在脂质体转染的HeLa细胞中的位点特异性整合。
Virology. 2000 Mar 15;268(2):391-401. doi: 10.1006/viro.1999.0122.
4
Targeted integration of adeno-associated virus-derived plasmids in transfected human cells.腺相关病毒衍生质粒在转染的人细胞中的靶向整合。
Virology. 1998 Sep 30;249(2):249-59. doi: 10.1006/viro.1998.9332.
5
Site-specific integration of functional transgenes into the human genome by adeno/AAV hybrid vectors.腺病毒/腺相关病毒杂交载体介导功能性转基因在人类基因组中的位点特异性整合
Mol Ther. 2004 Oct;10(4):660-70. doi: 10.1016/j.ymthe.2004.07.003.
6
The transient expression of mRNA coding for Rep protein from AAV facilitates targeted plasmid integration.来自腺相关病毒(AAV)的编码Rep蛋白的mRNA的瞬时表达促进了靶向质粒整合。
J Gene Med. 2008 Jan;10(1):42-50. doi: 10.1002/jgm.1118.
7
Recombinant adeno-associated virus (AAV-CFTR) vectors do not integrate in a site-specific fashion in an immortalized epithelial cell line.重组腺相关病毒(AAV-CFTR)载体不会以位点特异性方式整合到永生化上皮细胞系中。
Gene Ther. 1996 Sep;3(9):748-55.
8
Site-specific integration of a transgene mediated by a hybrid adenovirus/adeno-associated virus vector using the Cre/loxP-expression-switching system.使用Cre/loxP表达切换系统的杂交腺病毒/腺相关病毒载体介导的转基因位点特异性整合。
Biochem Biophys Res Commun. 2000 Jul 5;273(2):473-8. doi: 10.1006/bbrc.2000.2972.
9
Targeted transgene integration into transgenic mouse fibroblasts carrying the full-length human AAVS1 locus mediated by HSV/AAV rep(+) hybrid amplicon vector.通过单纯疱疹病毒/腺相关病毒rep(+)杂交扩增子载体介导,将靶向转基因整合到携带全长人AAVS1基因座的转基因小鼠成纤维细胞中。
Gene Ther. 2003 Sep;10(19):1691-702. doi: 10.1038/sj.gt.3302061.
10
Parvovirus-based vectors for human gene therapy.用于人类基因治疗的细小病毒载体。
Blood Cells. 1994;20(2-3):531-6; discussion 536-8.

引用本文的文献

1
AAV genome modification for efficient AAV production.用于高效生产腺相关病毒的腺相关病毒基因组修饰
Heliyon. 2023 Apr 1;9(4):e15071. doi: 10.1016/j.heliyon.2023.e15071. eCollection 2023 Apr.
2
Novel gene therapy viral vector using non-oncogenic lymphotropic herpesvirus.新型基因治疗病毒载体采用非致瘤性淋巴亲嗜性疱疹病毒。
PLoS One. 2013;8(2):e56027. doi: 10.1371/journal.pone.0056027. Epub 2013 Feb 11.
3
Gene delivery with viral vectors for cerebrovascular diseases.用于脑血管疾病的病毒载体基因递送
Front Biosci (Elite Ed). 2013 Jan 1;5(1):188-203. doi: 10.2741/e607.
4
Preferential integration of adeno-associated virus type 2 into a polypyrimidine/polypurine-rich region within AAVS1.2型腺相关病毒优先整合到AAVS1内富含多嘧啶/多嘌呤的区域。
J Virol. 2007 Sep;81(18):9718-26. doi: 10.1128/JVI.00746-07. Epub 2007 Jul 11.
5
Stable secondary structure near the nicking site for adeno-associated virus type 2 Rep proteins on human chromosome 19.人19号染色体上2型腺相关病毒Rep蛋白切割位点附近的稳定二级结构。
J Virol. 2005 Mar;79(6):3544-56. doi: 10.1128/JVI.79.6.3544-3556.2005.
6
Characterization of the mouse adeno-associated virus AAVS1 ortholog.小鼠腺相关病毒AAVS1直系同源物的特性分析。
J Virol. 2004 Aug;78(16):8917-21. doi: 10.1128/JVI.78.16.8917-8921.2004.
7
Efficient integration of recombinant adeno-associated virus DNA vectors requires a p5-rep sequence in cis.重组腺相关病毒DNA载体的有效整合在顺式条件下需要一个p5-Rep序列。
J Virol. 2002 Jun;76(11):5411-21. doi: 10.1128/jvi.76.11.5411-5421.2002.
8
A genetic screen identifies a cellular regulator of adeno-associated virus.一项基因筛选鉴定出腺相关病毒的一种细胞调节因子。
Proc Natl Acad Sci U S A. 2001 Dec 18;98(26):14991-6. doi: 10.1073/pnas.261567198. Epub 2001 Dec 4.
9
Targeted integration of foreign DNA into a defined locus on chromosome 19 in K562 cells using AAV-derived components.使用源自腺相关病毒(AAV)的组件将外源DNA靶向整合到K562细胞19号染色体的特定位点。
Int J Hematol. 2001 Jun;73(4):469-475. doi: 10.1007/BF02994009.
10
Efficient replication of adeno-associated virus type 2 vectors: a cis-acting element outside of the terminal repeats and a minimal size.2型腺相关病毒载体的高效复制:末端重复序列之外的顺式作用元件及最小尺寸
J Virol. 2000 Dec;74(24):11511-21. doi: 10.1128/jvi.74.24.11511-11521.2000.